Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

BMS Opdivo trial scores early goal

January 14, 2015 Research and Development, Sales and Marketing BMS, Merck, cancer nsclc, keytruda, nivolumab, opdivo

A late-stage trial of Bristol-Myers Squibb’s lung cancer drug Opdivo has been stopped early after showing promising results – but …
News
eliot_forster_immunocore_portrait_2

Immunocore names chief executive

January 14, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eliot Forster, immunocore

Oxford-based biotec Immunocore has announced the appointment of Dr Eliot Forster as its chief executive with immediate effect. Forster takes …
Appointment
Lilly image

Lilly, BMS and Merck unite for cancer trials

January 13, 2015 Research and Development, Sales and Marketing BMS, Cancer, Galunisertib, Merck, NSCLC, keytruda, lilly, oncology, opdivo

Lilly will test some of its compounds in combination with rival cancer drugs from Bristol-Myers Squibb and Merck, the companies …
News
Roche image

Roche teams up to tackle antibiotics resistance

January 13, 2015 Research and Development, Sales and Marketing Antibiotics, Fedora, Meiji, OP0595, Roche, Teixobactin

Roche is to collaborate with Japan-based pharma firm Meiji and Canadian Fedora – two companies specialising in the production of …
News
greg_weaver

Oryzon Genomics names CFO and executive VP

January 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gregory Weaver, Oryzon genomics

Spanish clinical stage biopharma firm Oryzon Genomics has appointed Gregory Weaver as its executive vice president and chief financial officer. …
Appointment
Roche image

Roche stakes $1 billion in cancer gene research firm

January 12, 2015 Research and Development, Sales and Marketing Cancer, Foundation Medicine, Genentech, Roche, genomics, jp morgan

Roche has announced a huge billion-dollar investment in the cancer genomics research firm Foundation Medicine. Timed with the beginning of …
News
FDA image

FDA approvals: 1996 versus 2014

January 12, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, LaMattina, NDA, US, appovals, drugs

As highlighted in a number of recent stories, 2014 was a banner year for the biopharmaceutical industry with 41 new …
Feature
atul_pande

Heptares Therapeutics hires former GSK heads

January 12, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atul Pande, GSK, Heptares, Roberto Solari

UK and US-based clinical-stage drug firm Heptares Therapeutics has appointed Atul Pande and Roberto Solari to its board of directors. …
Appointment
jo_brook

Ashfield Meetings & Events makes two appointments

January 9, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Meetings, ashfield, events, ian anderson, jo brook

Healthcare event management firm Ashfield Meetings & Events has appointed Jo Brook as an engagement director and Ian Anderson joins …
Appointment
23andme image

Genentech makes $10m gene testing outlay

January 8, 2015 Medical Communications, Research and Development, Sales and Marketing 23andME, DNA, Genentech, MHRA, Pfizer, Roche

Genentech has thrown its weight behind the contentious DNA testing company 23andMe, by agreeing a deal to buy the genomic …
News
Janssen image

Isis and J&J sign RNA deal

January 8, 2015 Research and Development, Sales and Marketing Isis, J&J, JJ, Janssen, RNA, gastrointestinal tract

Isis Pharmaceuticals is collaborating with Johnson & Johnson’s pharma unit Janssen to develop antisense drugs to treat autoimmune disorders. The …
News
darren_carroll

Lilly appoints head of business development

January 8, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing darren carroll, lilly

Eli Lilly has promoted Darren Carroll to senior vice president of its corporate business development unit. Carroll has fulfilled the …
Appointment

Gilead acquires Phenex liver disease drugs

January 7, 2015 Research and Development, Sales and Marketing Farnesoid X Receptor, Gilead, liver, nafld, nash, phenex

Gilead Sciences has acquired Phenex Pharmaceuticals’ development programme for the treatment of serious liver diseases. The US biopharma firm will …
News
Amgen image

Amgen and Novartis start cancer immunotherapy push

January 7, 2015 Research and Development, Sales and Marketing Amgen, Caribou Biosciences, Intellia Therapeutics, Novartis, kite pharma

Amgen and Novartis have launched new licensing agreements with biotech companies that they hope will lead to the development of …
News
danielle_guildford

Liberation Unlimited promotes Danielle Guildford-Sharp

January 7, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Creston, Danielle Guildford-Sharp, health unlimited, liberation unlimited

UK marketing and communications agency Liberation Unlimited has promoted Danielle Guildford-Sharp to the role of account manager. Since joining Liberation …
Appointment
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026